secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001370053-25-000083
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio holds ANB033 (CD122 antagonist) investor event; updates corporate presentation
--------------------------------------------------------------------------------

- Conference call and slide presentation on ANB033 (CD122 antagonist) held on October 14, 2025.
- Updated corporate investor presentation filed as Exhibit 99.2; no specific clinical or financial data disclosed in the filing text.
- Event intended to provide pipeline update; details of ANB033 discussion not expanded in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000083/0001370053-25-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000083/anab-20251014.htm
  HTML page:      https://secwatch.observer/filing/0001370053-25-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer